The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Behandlingsprogram vid ascites. Rekommendationer fran Svensk forening for gastroenterologi och gastrointestinal endoskopi

[Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy]

På svenska

Author

  • Lars Lööf
  • Hanne Prytz
  • Claes Söderlund
  • Sven Wallerstedt

Summary, in English

As ascites is related to liver cirrhosis in 80% of the patients, the present therapeutic guidelines are focused on ascites in liver cirrhosis. A combination of spironolactone and furosemide is recommended as first line therapy in patients with mild to moderate ascites and is effective in 90% of patients. In patients with pronounced or tense ascites, first line treatment is total paracentesis with intravenous infusion of human albumin as colloid replacement. Maintenance therapy for the prevention of recurrent ascites is based on spironolactone with or without furosemide. The indications for peritoneovenous shunt, or transjugular intrahepatic stent-shunt (TIPSS), are limited and only recommended in strictly selected patients with refractory ascites. Ascites in liver cirrhosis is a symptom of advanced liver disease, and liver transplantation should always be considered in eligible patients.

Department/s

Publishing year

2001

Language

Swedish

Pages

5649-5655

Publication/Series

Läkartidningen

Volume

98

Issue

49

Document type

Journal article

Publisher

Swedish Medical Association

Topic

  • Other Clinical Medicine

Status

Published

ISBN/ISSN/Other

  • ISSN: 0023-7205